Ozempic goes from threat to opportunity for packaged-food makers
Briefly

Nestle SA has launched an entire product line of frozen food that specifically target those taking the drugs, known as GLP-1s.
‘Just like everyone else, we felt nervous when those surveys came out,’ said Bob Nolan, senior vice president of demand science at Conagra.
Even makers of cookies and snacks say that their data shows that the impact on caloric intake is likely to be very limited.
Nicholas Fereday, a senior analyst at Rabobank, said that companies can still be hurt by the trend, especially snack companies.
Read at Fortune
[
|
]